Venture Insights On Retinal Innovation

Exciting insights from the OIS Retina Panel! Moderated by Dr. Emmett Cunningham, this discussion dives deep into the current state of ophthalmology investment and innovation. Panelists, Anna Chen, Adit Ghosh, Dr. Firas Rahhal and Caroline Stout shared their perspectives on the evolving landscape, highlighting both opportunities and challenges in the field.

Here are the key takeaways:

• Cautious Optimism: A resurgence in private markets, but drug development challenges persist.
• Growth Areas: Focus on drug delivery, extended-release biologics, and complement inhibitors for dry AMD/GA.
• Strategic Partnerships: Crucial for commercialization in ophthalmology.
• Emerging Trends: AI’s potential impact and regulatory changes in drug discovery.
• Market Concerns: Uncertainties around gene therapy and commercial viability.

Don’t miss out—listen in now to gain valuable insights!